Bulky Picolyl Substituted NHC Ligands and Their Pd0 Complexes
H, CH], 7.08 (s, 1 H, aryl-H), 6.91 (s, 1 H, aryl-H), 6.85 [d, 3J(H,H)
p-aryl-C, 2 i-aryl-C, 4 o-aryl-C), 128.9, 128.5, 128.2, 127.3 (4 m-
aryl-CH), 125.9 (CH), 122.7 (5-pyr-CH), 121.7 (3-pyr-CH), 120.9
(CH), 56.4 (CH2), 39.9 (alkene), 37.8 (alkene), 20.8 (2 p-aryl-CH3),
2
= 1.2 Hz, 1 H, CH], 5.41 [d, J(H,H) = 15 Hz, 1 H, CH2], 5.12 [d,
2J(H,H) = 15 Hz, 1 H, CH2], 3.30 (br. s, 1 H, ma), 3.08 (br. s, 1 H,
ma), 2.37 (s, 3 H, p-aryl-CH3), 2.05 (s, 3 H, o-aryl-CH3), 1.92 (s, 3 20.5, 20.3 (2 o-aryl-CH3), 17.7, 17.6 (2 o-aryl-CH3). MS (FAB+,
H, o-aryl-CH3). 13C NMR (CD2Cl2): δ = 188.7 (NCN), 173.6 (CO), m/z): calcd. for C27H29N3Pd [M – ma]+ 501.1396; found 501.1410.
173.5 (CO), 155.9 (6-pyr-C), 154.3 (2-pyr-CH), 139.8 (4-pyr-C),
{[1-(2-Pyridyl)methylene-3-(2,6-diisopropylphenyl)]imidazol-2-
139.1 (p-aryl-C), 137.1 (i-aryl-C), 136.1 (o-aryl-C), 135.6 (o-aryl-
ylidene}palladium(0) Maleic Anhydride (14a): The product (83 mg,
C), 129.6 (m-aryl-CH), 128.9 (m-aryl-CH), 125.4 (CH), 125.2
98%) was obtained as yellow crystals. 1H NMR (CD2Cl2): δ = 8.83
(m, 1 H, 6-pyr-H), 7.88 (m, 1 H, 4-pyr-H), 7.57 (m, 1 H, 3-pyr-H),
(CH), 123.4 (5-pyr-CH), 121.8 (3-pyr-CH), 55.9 (CH2), 41.5 (al-
kene), 40.4 (alkene), 21.4 (p-aryl-CH3), 18.1 (br., o-aryl-CH3). MS
7.48 [t, J(HH) = 7.8 Hz, 1 H, p-aryl-H], 7.39 (m, 1 H, 5-pyr-H),
(FAB+, m/z): calcd. for C22H22N3O3Pd [M + H]+ 482.0696; found
7.29 [d, 3J(HH) = 7.8 Hz, 2 H, m-aryl-H], 7.26 [d, 3J(HH) = 1.8 Hz,
482.0675.
1 H, CH], 6.95 [d, 3J(HH) = 1.8 Hz, 1 H, CH], 5.27 (br. s, 2 H,
CH2), 3.34 (br. s, 2 H, ma), 2.58–2.24 (2 br. m, 2 H, iPr), 1.28 [br.
({1-[2-(6-Methyl)pyridyl]methylene-3-mesityl}imidazol-2-ylidene)pal-
d, 3J(HH) = 6.6 Hz, 6 h, iPr], 1.05 [br. d, 3J(HH) = 6.9 Hz, 6 h,
ladium(0) Maleic Anhydride (13b): The product (0.13 g, 96%) was
iPr]. 13C NMR (CD2Cl2): δ = 190.1 (NCN), 172.6 (CO), 172.3
(CO), 154.1 (6-pyr-CH), 153.8 (2-pyr-C), 145.8 (o-aryl-CH), 138.7
(4-pyr-CH), 136.2 (i-aryl-C), 129.8 (p-aryl-C), 125.0 (m-aryl-C),
124.0 (CH), 123.8 (CH), 123.0 (5-pyr-CH), 121.1 (3-pyr-CH), 55.7
(CH2), 41.2 (alkene), 40.8 (alkene), 29.9 (iPr-CH), 24.6 (iPr-CH3),
23.7 (iPr-CH3). MS (FAB+, m/z): calcd. for C25H28N3O3Pd [M +
H]+ 524.1165; found 524.1174. C25H27N3O3Pd (537.12): calcd. C
54.39, H 5.19, N 8.02; found C 54.50, H 5.31, N 7.69.
obtained as a yellow solid. 1H NMR (CD2Cl2): δ = 7.72 [dd, J(HH)
3
3
= 7.5, J(HH) = 7.8 Hz, 1 H, 4-pyr-H], 7.37 [d, J(HH) = 7.5 Hz,
1 H, 3-pyr-H], 7.34 3J(HH) = 7.8 Hz, 1 H, 5-pyr-H(), 7.29 [d,
3J(HH) = 1.8 Hz, 1 H, CH], 7.09 (br. s, 1 H, aryl-H), 6.97 (br. s, 1
H, aryl-H), 6.91 [d, 3J(HH) = 1.8 Hz, 1 H, CH], 5.50 [br. d, 2J(HH)
2
= 13.5 Hz, 1 H, CH2], 5.09 [br. d, J(HH) = 13.5 Hz, 1 H, CH2],
3.36 (br. s, 1 H, ma), 3.10 (br. s, 1 H, ma), 2.81 (s, 3 H, pyr-CH3),
2.37 (s, 3 H, p-aryl-CH3), 2.15 (br. s, 3 H, o-aryl-CH3), 1.86 (br. s,
3 H, o-aryl-CH3). 13C NMR (CD2Cl2): δ = 190.0 (NCN), 174.0
(CO), 173.3 (CO), 161.8 (6-pyr-C), 154.1 (2-pyr-C), 138.8 (p-aryl-
C), 138.4 (4-pyr-CH), 136.7 (i-aryl-C), 135.9 (o-aryl-C), 135.6 (o-
aryl-C), 129.0 (m-aryl-CH), 128.7 (m-aryl-CH), 124.5 (5-pyr-CH),
122.1 (CH), 121.6 (3-pyr-CH), 121.2 (CH), 56.2 (CH2), 39.3 (al-
kene), 39.2 (alkene), 29.0 (pyr-CH3), 21.1 (p-aryl-CH3), 17.9 (o-
aryl-CH3), 17.7 (o-aryl-CH3). MS (FAB+, m/z): calcd. for
C2 3 H2 4 N3 O3 Pd [ M + H]+ 4 9 6 . 0 8 5 2 ; fo u nd 4 96 . 0 86 6.
C23H23N3O3Pd (495.08): calcd. C 55.71, H 4.68, N 8.47; found C
55.70, H 4.74, N 8.23.
({1-[2-(6-Methyl)pyridyl]methylene-3-(2,6-diisopropylphenyl)}imid-
azol-2-ylidene)palladium(0) Maleic Anhydride (14b): The product
1
(0.13 g, 98%) was obtained as a yellow solid. H NMR (CD2Cl2):
3
3
δ = 7.74 [dd, J(HH) = 7.5, J(HH) = 7.8 Hz, 1 H, 4-pyr-H], 7.47
[t, 3J(HH) = 7.8 Hz, 1 H, p-aryl-H], 7.37 [d, 3J(HH) = 7.5 Hz, 1
H, 3-pyr-H], 7.35 {d, [d, 3J(HH) = 7.8 Hz, 1 H, 5-pyr-H]}, 7.30
3
(m, 2 H, m-aryl-H), 7.25 [d, J(HH) = 2.1 Hz, 1 H, CH], 6.95 [d,
3J(HH) = 2.1 Hz, 1 H, CH], 5.50 (br. s, 1 H, CH2), 5.23 (br. s, 1
H, CH2), 3.32 (s, 2 H, ma), 2.78 (s, 3 H, pyr-CH3), 2.64 (br. m, 1
H, iPr-H), 2.37 (br. m, 1 H, iPr-H), 1.4–1.0 (br. m, 12 H, iPr-CH3).
13C NMR (CD2Cl2): δ = 191.4 (NCN), 173.4 (CO), 173.2 (CO),
162.3 (6-pyr-C), 154.0 (2-pyr-C), 146 (br., o-aryl-C), 138.3 (4-pyr-
CH), 136.3 (i-aryl-C), 129.6 (p-aryl-CH), 126.8 (m-aryl-CH), 125.2
(m-aryl-CH), 124.5 (5-pyr-CH), 123.8 (CH), 121.8 (3-pyr-CH),
120.8 (CH), 56.4 (CH2), 39.4 (alkene), 39.2 (alkene), 29.3 (iPr-CH),
28.8 (iPr-CH), 28.5 (pyr-CH3), 26.0 (iPr-CH3), 25.1 (iPr-CH3),
24.1, (iPr-CH3), 23.6 (iPr-CH3). MS (FAB+, m/z): calcd. for
C22H27N3Pd [M – ma]+ 439.1240; found 439.1251.
({1-[2-(6-Phenyl)pyridyl]methylene-3-mesityl}imidazol-2-ylidene)pal-
ladium(0) Maleic Anhydride (13c): The product (48 mg, 98%) was
obtained as a yellow solid. 1H NMR (CD2Cl2): δ = 8.09 [d, 3J(H,H)
3
3
= 4.5 Hz, 2 H, Ph], 7.78 [dd, J(H,H) = 4.5, J(H,H) = 4.5 Hz, 1
3
H, 4-pyr-H], 7.70 [d, J(H,H) = 4.5 Hz, 1 H, 3-pyr-H], 7.5–7.4 (m,
3 H, 5-pyr-H, Ph), 7.14 (s, 1 H, CH), 7.08 (s, 2 H, aryl-H), 6.90 (s,
1 H, CH), 4.9–4.6 (br. s, 2 H, CH2), 3.02 (br. s, 1 H, ma), 2.41 (s,
3 H, p-aryl-CH3), 2.11 (s, 1 H, ma), 1.92 (br. s, 6 H, o-aryl-CH3).
13C NMR (CD2Cl2): δ = 191.5 (NCN), 174.1 (CO), 157.8 (6-pyr-
C), 156.6 (2-pyr-C), 139.3 (4-pyr-CH), 139.0, 138.0, 136.9, 136.7
(p-aryl-C, p-Ph–CH, i-aryl-C, i-Ph–C), 136.2 (o-aryl-C), 135.9 (o-
aryl-C), 129.4 (m-aryl-CH), 129.2 (m-aryl-CH), 128.8 (Ph-CH),
127.0 (Ph-CH), 123.4 (5-pyr-CH), 121.3 (CH), 121.0 (3-pyr-CH),
119.1 (CH), 55.9 (CH), 39.4 (alkene), 21.0 (p-aryl-CH3), 18.0 (o-
aryl-CH3), 17.6 (o-aryl-CH3). MS (FAB+, m/z): calcd. for
C24H23N3Pd [M – ma]+ 459.0927; found 459.0930.
{[1-(2-Pyridyl)methylene-3-(4-methoxyphenyl)]imidazol-2-ylidene}-
palladium(0) Maleic Anhydride: The product could be identified in
1H NMR, although decomposition was too rapid to assign the
spectrum.
{[1-(2-Pyridyl)methylene-3-(4-trifluoromethylphenyl)]imidazol-2-
ylidene}palladium(0) Maleic Anhydride: The product (18 mg, 26%)
was obtained as a yellow solid which decomposed over the course
1
of several hours. H NMR (CD2Cl2): δ = 8.88 (m, 1 H, 6-pyr-H),
7.92–7.81 (m, 6 H, aryl-H, CH, 4-pyr-H), 7.55 (m, 1 H, 3-pyr-H),
7.40 (m, 1 H, 5-pyr-H), 7.29 [d, J(HH) = 2.1 Hz, 1 H, CH], 5.40–
5.16 (2 br. d, 2 H, CH2), 3.80–3.40 (2 br. d, 2 H, ma).
({1-[2-(6-Mesityl)pyridyl]methylene-3-mesityl}imidazol-2-ylidene)pal-
ladium(0) Maleic Anhydride (13d): The product (83 mg, 95%) was
obtained as an ochre solid. 1H NMR (CD2Cl2): δ = 7.90 [dd,
3
3
3
3J(H,H) = 7.8, J(H,H) = 7.8 Hz, 1 H, 4-pyr-H], 7.54 [d, J(H,H)
X-ray Data Collection, Reduction, and Refinement: A suitable single
= 7.8 Hz, 1 H, 3-pyr-H], 7.35 [d, J(H,H) = 7.8 Hz, 1 H, 5-pyr-H], crystal of 13b was coated with Paratone-N oil, mounted using a
3
3
7.30 [d, J(H,H) = 2.1 Hz, 1 H, CH], 7.06 (br. s, 2 H, pyr-aryl-H),
glass fibre pin and frozen in the cold nitrogen stream of the goni-
ometer. X-ray diffraction data was collected on a Bruker AXS
APEX CCD diffractometer equipped with a rotation anode at
153(2) K using graphite-monochromated Mo-Kα radiation (λ =
0.71073 Å) with a scan width of 0.3° and exposure time of 15 s.
The generator setting was 50 kV and 160 mA. Diffraction data was
collected over the full sphere and the frames were integrated using
3
6.95 (br. s, 1 H, aryl-H), 6.89 [d, J(H,H) = 2.1 Hz, 1 H, CH], 6.87
(br. s, 1 H, aryl-H), 5.66 [d, 2J(H,H) = 14.4 Hz, 1 H, CH2], 5.12
2
[d, J(H,H) = 14.4 Hz, 1 H, CH2], 2.83 (br. s, 1 H, ma), 2.36 (s, 3
H, p-aryl-CH3), 2.32 (s, 3 H, p-aryl-CH3), 2.06 (s, 3 H, o-aryl-CH3),
1.99 (s, 3 H, o-aryl-CH3), 1.89 (s, 3 H, o-aryl-CH3), 1.86 (s, 3 H,
o-aryl-CH3), 1.61 (br. s, 1 H, ma). 13C NMR (CD2Cl2): δ = 190.4
(NCN), 173.9 (CO), 172.6 (CO), 163.7 (6-pyr-C), 154.6 (2-pyr-C), the Bruker SMART[22] software package using the narrow frame
139.1 (4-pyr-CH), 138.4, 138.2, 138.0, 136.6, 136.4, 136.0, 134.6 (2
algorithm. Data were corrected for absorption effects using the SA-
Eur. J. Inorg. Chem. 2010, 5556–5562
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
5561